how to novartis in India help the poor while have profitable ethical business
he Supreme Court in India ruled on Monday that Novartis, the pharmaceutical company, should not be given a patent for a cancer drug because it was too similar to Novartis’s earlier version. The decision, which is the culmination of a high-profile, seven-year legal battle, should help protect the availability of cheap generic drugs for poor patients.